A second genetic risk factor for Alzheimer's disease has been discovered
The results of the study open the way to the development of new classes of drugs for the treatment of Alzheimer's disease. The high selectivity of the action of such drugs is assumed, since, unlike the ApoE gene, the CALHM1 gene is active only in the brain.
26.06.2008